Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
Valproic acid A.2. What is the underlying pathology? A.5. Describe the hematologic side effects of chronic valproic acid therapy. B.1. What preoperative evaluation and testing would you recommend for this patient prior to anesthesia? Coagulopathy D.4. What is the role of antiseizure prophylaxis in the perioperative management of head trauma?
Valsartan B.6. How should the patient's other medications be managed before surgery? Ischemic Heart Disease and Noncardiac Surgery
Vancomycin B.2. How would you premedicate this patient? Why? B.3. How are routine medications and immunosuppressive medications managed in the perioperative period?
Vasopressin
Vecuronium
Venlafaxine B.6. Are there any psychiatric medications he is taking that would impact your anesthetic care? Electroconvulsive Therapy
Verapamil A.14. What is the mechanism of action of the major antihypertensive drugs? A.17. Describe the operative procedure of kidney transplantation. A.6. Which perioperative medical therapies would you employ to reduce the incidence of myocardial ischemia? C.1. Are a central venous pressure (CVP) catheter, an arterial catheter, and a pulmonary artery catheter required for the transplant procedure? C.10. During the surgery, the blood pressure increases to 220/120 mm Hg. How would you treat the hypertension? C.11. What could you do to prevent hypertension during tracheal extubation and emergence? C.11. When would you extubate the trachea in this patient? What could you do to prevent hypertension and tachycardia during extubation and emergence? C.6. Twenty minutes into the procedure with sevoflurane anesthesia, the patient develops increasing tachycardia with ventricular premature beats and mottled skin. What emergency measures should you take? D.1. The patient developed hypertension, BP 210/110 mm Hg, in the postanesthesia care unit. What would you do?
Visken
Vitamin B12
Vitamin D A.3. What are the metabolic and endocrine abnormalities in patients with 22q11 deletion syndrome and the attendant manifestations? A.4. What are the common clinical manifestations of ESRD? A.4. What are the functions of the skin? A.5. What electrolyte imbalances occur in patients with impaired renal function, and how are they treated? A.7. Are patients with renal disease at increased risk of cardiovascular disease? B.6. Are there any psychiatric medications he is taking that would impact your anesthetic care?
Vitamin K B.1. How would you assess this patient preoperatively? B.9. What coagulation abnormalities are present after TBI? What modalities can be used to provide hemostasis and reduce intracranial hematoma expansion? C.10. If this patient had a massive blood loss, what blood replacement therapy would be indicated? C.11. What is the role of recombinant activated factor VII (rFVIIa) in the hemorrhaging obstetric patient? C.21. What concentrated factors and hemostatic agents are available for bleeding patients? C.9. Two hours later, estimated blood loss (EBL) is approximately 2 L and the patient has been resuscitated with 3 units of packed red blood cells (pRBCs), 229 mL intraoperative cell salvage (cell saver), and 500 mL albumin in addition to 4 L crystalloid. The surgeon says the field is still "oozy" and there is ongoing blood loss. What are your concerns for resuscitation moving forward? How will you guide your resuscitation?